{
    "Title": "Serological response to nifurtimox in adult patients with chronic Chagas disease: An observational comparative study in Argentina",
    "URL": "https://doi.org/10.1371/journal.pntd.0009801",
    "Published": "October 4, 2021",
    "Subject_Areas": [
        "Chagas disease",
        "Electrocardiography",
        "Parasitic diseases",
        "Enzyme-linked immunoassays",
        "Laboratory tests",
        "Parasitology",
        "Serodiagnosis",
        "Signs and symptoms"
    ],
    "Authors": {
        "David Vizcaya": [
            "Bayer Pharmaceuticals, Sant Joan Despi, Spain"
        ],
        "Ulrike Grossmann": [
            "Bayer AG, Berlin, Germany"
        ],
        "Frank Kleinjung": [
            "Bayer AG, Berlin, Germany"
        ],
        "Ruiping Zhang": [
            "Bayer HealthCare, Beijing, China"
        ],
        "Kiliana Suzart-Woischnik": [
            "Bayer AG, Berlin, Germany"
        ],
        "Sandra Seu": [
            "Centro de Chagas y Patología Regional, Hospital Independencia, Santiago del Estero, Argentina"
        ],
        "Teresa Ramirez": [
            "Centro de Chagas y Patología Regional, Hospital Independencia, Santiago del Estero, Argentina"
        ],
        "Leylen Colmegna": [
            "LAT Research, Buenos Aires, Argentina"
        ],
        "Oscar Ledesma": [
            "Centro de Chagas y Patología Regional, Hospital Independencia, Santiago del Estero, Argentina"
        ]
    }
}